Active Ingredient History
A blood product is any therapeutic substance prepared from human blood. This includes whole blood; blood components; and plasma derivatives. Whole blood is not commonly used in transfusion medicine. Blood components include: red blood cell concentrates or suspensions; platelets produced from whole blood or via apheresis; plasma; and cryoprecipitate. Plasma derivatives are plasma proteins prepared under pharmaceutical manufacturing conditions, these include: albumin; coagulation factor concentrates; and immunoglobulins. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acquired Immunodeficiency Syndrome (Phase 2)
Allografts (Phase 3)
Anemia (Phase 3)
Anemia, Sickle Cell (Phase 4)
Arthroplasty (Phase 4)
Blood Platelet Disorders (Phase 3)
Blood Transfusion (Phase 3)
Blood Transfusion, Autologous (Phase 3)
Chronic Limb-Threatening Ischemia (Phase 2)
Dopamine (Phase 3)
Doping in Sports (Phase 3)
Epinephrine (Phase 3)
Healthy Volunteers (Phase 2)
Hematologic Diseases (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 2/Phase 3)
Hip Fractures (Phase 1)
Hypertension, Pulmonary (Phase 4)
Immune Tolerance (Early Phase 1)
Kidney Transplantation (Phase 4)
Leukemia (Phase 1/Phase 2)
Liver Transplantation (Early Phase 1)
Lymphoma (Phase 1)
Lymphoma, B-Cell (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Sepsis (Phase 4)
Shock (Phase 3)
Shock, Septic (Phase 3)
Tooth Abnormalities (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
